NCLEX-RN Pharmacology
Gastrointestinal System Practice
Questions
20 Original NCLEX NGN-Style MCQs
with Detailed Rationales
ATI Pharmacology Made Easy Review
Nursing Exam Prep Study Guide
Question 1
Clinical Scenario
A 68-year-old man is admitted with melena and epigastric pain.
An upper endoscopy confirms a bleeding duodenal ulcer. His
history includes osteoarthritis treated with ibuprofen for several
years and hypertension controlled with lisinopril. The provider
prescribes pantoprazole 40 mg IV twice daily. The nurse
prepares to administer the first dose. Vital signs are stable, and
laboratory results show a hemoglobin of 9.6 g/dL.
Question Stem
,Which explanation best describes the primary therapeutic
action of pantoprazole in this patient?
A. It neutralizes gastric acid already present in the stomach.
B. It irreversibly inhibits the gastric proton pump, reducing acid
secretion.
C. It coats the ulcer surface to protect it from gastric acid.
D. It increases gastric emptying to decrease acid exposure.
Correct Answer
B. It irreversibly inhibits the gastric proton pump, reducing
acid secretion.
Detailed Rationale
Pantoprazole is a proton pump inhibitor (PPI) that irreversibly
blocks the hydrogen-potassium ATPase enzyme ("proton
pump") in gastric parietal cells, producing profound suppression
of gastric acid secretion. Reduced acid promotes clot
stabilization, ulcer healing, and decreases the risk of recurrent
gastrointestinal bleeding. Because the inhibition is irreversible,
acid production remains suppressed until new proton pumps
are synthesized.
Option A describes antacids such as calcium carbonate or
magnesium hydroxide, which neutralize existing stomach acid
but do not significantly reduce future acid production.
,Option C describes sucralfate, which forms a protective barrier
over ulcers but does not inhibit acid secretion.
Option D describes promotility agents such as metoclopramide,
which increase gastric emptying but are not first-line therapy
for bleeding peptic ulcers.
Nursing care includes monitoring hemoglobin, hematocrit, stool
color, abdominal pain, and signs of recurrent bleeding. Long-
term PPI therapy requires monitoring for risks such as
hypomagnesemia, vitamin B12 deficiency, osteoporosis-related
fractures, and Clostridioides difficile infection. Patients should
avoid unnecessary NSAID use and receive education regarding
ulcer prevention.
Learning Objectives
After completing this question, the learner should be able to:
• Explain the mechanism of action of proton pump
inhibitors.
• Identify appropriate nursing monitoring for GI bleeding.
• Differentiate PPIs from antacids and mucosal protectants.
• Recognize long-term safety considerations of PPIs.
Medication Safety Focus
Mechanism of action and monitoring
, Question 2
Clinical Scenario
A 56-year-old woman with gastroesophageal reflux disease
(GERD) has been taking omeprazole daily for eight months.
During a routine follow-up visit, she reports muscle cramps,
fatigue, and occasional tingling in her hands. Laboratory studies
reveal a magnesium level of 1.2 mg/dL (normal: 1.7–2.2
mg/dL).
Question Stem
Which nursing action is the priority?
A. Encourage the patient to continue therapy because these
symptoms are expected.
B. Notify the provider because prolonged proton pump
inhibitor therapy may contribute to hypomagnesemia.
C. Recommend increasing dietary sodium intake.
D. Advise the patient to take the medication with milk.
Correct Answer
B. Notify the provider because prolonged proton pump
inhibitor therapy may contribute to hypomagnesemia.
Detailed Rationale
Gastrointestinal System Practice
Questions
20 Original NCLEX NGN-Style MCQs
with Detailed Rationales
ATI Pharmacology Made Easy Review
Nursing Exam Prep Study Guide
Question 1
Clinical Scenario
A 68-year-old man is admitted with melena and epigastric pain.
An upper endoscopy confirms a bleeding duodenal ulcer. His
history includes osteoarthritis treated with ibuprofen for several
years and hypertension controlled with lisinopril. The provider
prescribes pantoprazole 40 mg IV twice daily. The nurse
prepares to administer the first dose. Vital signs are stable, and
laboratory results show a hemoglobin of 9.6 g/dL.
Question Stem
,Which explanation best describes the primary therapeutic
action of pantoprazole in this patient?
A. It neutralizes gastric acid already present in the stomach.
B. It irreversibly inhibits the gastric proton pump, reducing acid
secretion.
C. It coats the ulcer surface to protect it from gastric acid.
D. It increases gastric emptying to decrease acid exposure.
Correct Answer
B. It irreversibly inhibits the gastric proton pump, reducing
acid secretion.
Detailed Rationale
Pantoprazole is a proton pump inhibitor (PPI) that irreversibly
blocks the hydrogen-potassium ATPase enzyme ("proton
pump") in gastric parietal cells, producing profound suppression
of gastric acid secretion. Reduced acid promotes clot
stabilization, ulcer healing, and decreases the risk of recurrent
gastrointestinal bleeding. Because the inhibition is irreversible,
acid production remains suppressed until new proton pumps
are synthesized.
Option A describes antacids such as calcium carbonate or
magnesium hydroxide, which neutralize existing stomach acid
but do not significantly reduce future acid production.
,Option C describes sucralfate, which forms a protective barrier
over ulcers but does not inhibit acid secretion.
Option D describes promotility agents such as metoclopramide,
which increase gastric emptying but are not first-line therapy
for bleeding peptic ulcers.
Nursing care includes monitoring hemoglobin, hematocrit, stool
color, abdominal pain, and signs of recurrent bleeding. Long-
term PPI therapy requires monitoring for risks such as
hypomagnesemia, vitamin B12 deficiency, osteoporosis-related
fractures, and Clostridioides difficile infection. Patients should
avoid unnecessary NSAID use and receive education regarding
ulcer prevention.
Learning Objectives
After completing this question, the learner should be able to:
• Explain the mechanism of action of proton pump
inhibitors.
• Identify appropriate nursing monitoring for GI bleeding.
• Differentiate PPIs from antacids and mucosal protectants.
• Recognize long-term safety considerations of PPIs.
Medication Safety Focus
Mechanism of action and monitoring
, Question 2
Clinical Scenario
A 56-year-old woman with gastroesophageal reflux disease
(GERD) has been taking omeprazole daily for eight months.
During a routine follow-up visit, she reports muscle cramps,
fatigue, and occasional tingling in her hands. Laboratory studies
reveal a magnesium level of 1.2 mg/dL (normal: 1.7–2.2
mg/dL).
Question Stem
Which nursing action is the priority?
A. Encourage the patient to continue therapy because these
symptoms are expected.
B. Notify the provider because prolonged proton pump
inhibitor therapy may contribute to hypomagnesemia.
C. Recommend increasing dietary sodium intake.
D. Advise the patient to take the medication with milk.
Correct Answer
B. Notify the provider because prolonged proton pump
inhibitor therapy may contribute to hypomagnesemia.
Detailed Rationale
